A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.
Reviewed by Megan Craig, M.Sc.Oct 24 2023 This new ability to trigger programmed cell death could open the door for improved cancer treatments. The findings were published Oct. 14 in the Nature journal Cell Death & Differentiation.
We have found the most critical epitope for cytotoxic Fas signaling, as well as CAR T-cell bystander anti-tumor function." Finding better cancer therapies Cancer is generally managed with surgery, chemotherapy and radiotherapy. These treatments may work initially, but in some cases, therapy-resistant cancers often return. Immunotherapies, such as CAR T-cell-based immune therapies and immune checkpoint receptor molecule activating antibodies, have shown tremendous promise to break this cycle.
Death receptors do precisely what their name implies -; when targeted, they trigger programmed cell death of tumor cells. They offer a potential workaround that could simultaneously kill tumor cells and pave the way for more effective immunotherapies and CAR T-cell therapy. Other research in animal models and human clinical trials has shown that Fas signaling is fundamental to CAR T success, particularly in tumors that are genetically heterogeneous. Genetically heterogeneous tumors have a mix of different cell types, which can respond differently to treatment.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Researchers develop new resource to aid in cancer surveillance at US cancer centersWith the creation of Cancer InFocus, the University of Kentucky Markey Cancer Center's Community Impact Office introduced a new tool monitoring the geographic burden of cancer.
続きを読む »
Researchers show how cancer cells resist chemotherapyA study in human cell lines reveals cancer cells can activate a force-generating mechanism to survive a cancer therapy.
続きを読む »
Davis Cup: Great Britain captain Leon Smith names unchanged side for Davis Cup finalGreat Britain captain Leon Smith has announced an unchanged team for the Davis Cup quarter-final in Malaga
続きを読む »
Researchers identify 'switch' to activate cancer cell deathA research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die. This new ability to trigger programmed cell death could open the door for improved cancer treatments. The findings were published Oct.
続きを読む »
University of Cincinnati Cancer Center receives Institutional Research Grant from American Cancer SocietyThe American Cancer Society has awarded the University of Cincinnati Cancer Center an Institutional Research Grant.
続きを読む »
Linda Nolan is 'absolutely honoured' with new title amid cancer battleThe family have been affected by several cancer tragedies including the loss of Bernie in 2013 and earlier this year Linda, who had beaten cancer previously, revealed she had brain cancer.
続きを読む »